Canadian Association of Gastroenterology Position Statement: Fecal Microbiota Transplant Therapy

Canadian Association of Gastroenterology position statement: fecal microbiota transplant therapy.

Propofol use for sedation during endoscopy in adults: a Canadian Association of Gastroenterology position statement.

Over the past decade, multiple clinical reports have demonstrated that the use of propofol sedation for gastrointestinal endoscopy by gastroenterologists and trained endoscopy nurses is safe and effective in appropriately selected patients. Proposed benefits of propofol sedation include rapid onset of action, improved patient comfort and rapid clearance, as well as prompt recovery and discharge...

Canadian Association of Gastroenterology position statement regarding the use of thiopurines for the treatment of inflammatory bowel disease.

1Division of Gastroenterology and Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, Ontario; 2Division of Gastroenterology & Nutrition, Dalhousie University, Halifax, Nova Scotia; 3Division of Gastroenterology, McGill University, Montreal, Quebec; 4Section of Gastroenterology, University of Manitoba, Winnipeg, Manitoba; 5Division of Gastroenterology, Queen’s U...

Canadian Association of Gastroenterology position statement on screening individuals at average risk for developing colorectal cancer: 2010.

The Canadian Association of Gastroenterology and the Canadian Digestive Health Foundation published guidelines on colon cancer screening in 2004. Subsequent to the publication of these guidelines, many advances have occurred, thereby necessitating a review of the existing guidelines in the context of new technologies and clinical knowledge. The assembled guideline panel recognized three recent ...

Factors Affecting Effectiveness of Fecal Microbiota Transplant